Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus

Nonalcoholic steatohepatitis (NASH) is a common chronic liver condition affecting obese patients with prediabetes or type 2 diabetes mellitus (T2DM). Pioglitazone seems to target metabolic defects,...